Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Lion Point Capital, LP
Form 13F · Q2 2026

Lion Point Capital, LP

CIK 1643354Filed 2026-08-1413F-HR View the filing on EDGAR ↗
$21M
Reported book value
35
Positions
12
Quarters on record
Top 50
Positions

Lion Point Capital, LP — holdings

Top 35 positions of 35, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1CUE Cue Biopharma Inc52,928—$2M8.0%
2PRAX Praxis Precision Medicines I4,450+0.0%$1M7.1%
3MLTX Moonlake Immunotherapeutics67,500+0.0%$1M6.3%
4FENC Fennec Pharmaceuticals Inc112,434+0.0%$1M5.8%
5RPRX Royalty Pharma Plc21,400+0.0%$1M5.7%
6CMPS Compass Pathways Plc80,000+0.0%$1M5.4%
7MIST Milestone Pharmaceuticals In820,000+0.0%$1M5.3%
8BNTC Benitec Biopharma Inc62,000+0.0%$829,5604.0%
9SNDX Syndax Pharmaceuticals Inc36,000+0.0%$786,9603.8%
10BHVN Biohaven Ltd51,700+0.0%$769,2963.7%
11GERN Geron Corp578,000+0.0%$739,8403.5%
12QURE Uniqure Nv14,700+0.0%$677,0823.2%
13ARDX Ardelyx Inc128,650+0.0%$656,1153.1%
14LNTH Lantheus Hldgs Inc5,500+0.0%$610,1702.9%
15IRON Disc Medicine Inc8,100+0.0%$592,4342.8%
16SRPT Sarepta Therapeutics Inc28,500+0.0%$512,1452.4%
17HUMA Humacyte Inc650,000+0.0%$507,2602.4%
18KURA Kura Oncology Inc46,000+0.0%$504,6202.4%
19VTRS Viatris Inc27,700+0.0%$439,8762.1%
20DYN Dyne Therapeutics Inc18,000+0.0%$399,7801.9%
21BBIO Bridgebio Pharma Inc5,000+0.0%$372,4001.8%
22EWTX Edgewise Therapeutics Inc9,100+0.0%$369,7331.8%
23PCRX Pacira Biosciences Inc13,500+0.0%$342,4951.6%
24RGNX Regenxbio Inc26,600+0.0%$318,6681.5%
25RCKT Rocket Pharmaceuticals Inc86,000+0.0%$294,1201.4%
26JANX Janux Therapeutics Inc19,000+0.0%$291,8401.4%
27MLYS Mineralys Therapeutics Inc10,500+0.0%$283,2901.4%
28GHRS Gh Research Plc10,200+0.0%$274,1761.3%
29MCRB Seres Therapeutics Inc31,570+0.0%$249,0871.2%
30AZTA Azenta Inc9,700+0.0%$247,5441.2%
31JSPR Jasper Therapeutics Inc465,000+0.0%$195,7650.9%
32INVA Innoviva Inc8,200+0.0%$186,2220.9%
33IPHA Innate Pharma S A81,151+0.0%$149,3180.7%
34ARQT Arcutis Biotherapeutics Inc5,250+0.0%$137,6550.7%
35SPRB Spruce Biosciences Inc1,000+0.0%$54,0000.3%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.